explore -WSS

explore

author：knowledge 2025-10-01 15:31:56 - browse：3

A protestor wears a transgender flag at a hearing on banning gender-affirming health care legislation in Missouri. AP Photo/Charlie Riedel

The American Academy of Pediatrics reaffirmed its support for gender-affirming medical care for transgender children on Thursday, even as the treatments face a growing push for bans and restrictions from Republican lawmakers across the U.S.

The board of directors for the group, which represents 67,000 pediatricians, unanimously voted to reaffirm its 2018 position on the treatments. The board also voted to provide additional documents to support pediatricians, including clinical and technical reports, and to conduct an external review of research regarding the care.

“The additional recommendations also reflect the fact that the board is concerned about restrictions to accessing evidence-based health care for young people who need it,” Mark Del Monte, the academy’s CEO, said in a statement released by the group, calling the restrictions enacted by states “unprecedented government intrusion.”

“We therefore need to provide the best and most transparent process possible,” he said.

At least 21 states have now enacted laws restricting or banning gender-affirming medical care for transgender minors, and most of those states face lawsuits. A federal judge struck down Arkansas’ ban as unconstitutional, and federal judges have temporarily blocked bans in Alabama and Indiana.

The judge who struck down Arkansas’ ban cited the position of the groups in his ruling against the ban. Arkansas has appealed the judge’s decision.

People opposed to such treatments for children argue they are too young to make such decisions about their futures.

Every major medical group, including the academy and the American Medical Association, has opposed the bans and has said the treatments are safe if administered properly.

The academy and the AMA support allowing children to seek the medical care, but they don’t offer age-specific guidance.

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Ibogaine psychedelic therapy for opioid addiction unlikely, official says

explore

WSS

Surgeons perform first xenotransplant using CRISPR'd pig kidney

Testing GLP

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

Designating disabled people as health disparity population is crucial

Chinese researcher claims birth of first gene

Caregivers of transplant patients call for more support, training

focus

explore

focus

Anesthesiologist group: stop taking Ozempic before surgery

Diabetes management: Digital health tools fall short, study says

Affirmative action in medical school literally saved lives

Three issues to watch in global health in 2024

United colonoscopy coverage change 'may cost lives,' doctors say

Pfizer, Moderna say biotech, pharma drug development is a sprint

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Designating disabled people as health disparity population is crucial

After affirmative action ruling, medical educators look to 'holistic review'

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

focus

Mirador, a new biotech startup, launches with $400 million

Medicare Advantage insurers pressure Biden for bigger payments

Diabetes management: Digital health tools fall short, study says

Adam's Take: Intra

U.K. officials, researchers try to ease path for bespoke genetic treatments

Doulas covered by Medicaid under New York's new plan

leisure time

hotspot

explore

focus